Understanding the characteristics of specific types of cancer and evaluating potential therapies.
Deputy Director: Gary Schwartz, M.D.
Although many cancers share fundamental features, the cancers of each organ system have unique characteristics that affect their diagnosis and treatment. The members of the disease-specific programs focus their attention on specific groups of diseases. Each program combines fundamental research activities with clinical exploration of therapies.
The Four Disease-Specific Programs At HICCC Are:
- Breast Cancer
Understanding the biology, genetics and biochemistry of breast cancer, and applying this knowledge towards diagnostic, therapeutic and preventive strategies.
- Lymphoid Development & Malignancy Studying the unique biology of B and T cells to elucidate the pathogenesis and improve the treatment of lymphoid leukemia and lymphoma.
- Prostate Cancer Enhancing our knowledge of the pathogenesis of prostate cancer and translating it into novel diagnostic methods and therapeutic strategies.
- Neuro-oncology Translating findings in cancer biology into new therapies for patients with primary brain tumors.